Professor Robert Coleman, MBBS, MD, FRCP, FRCPE
Emeritus Professor of Medical Oncology
Development of new treatments and management strategies for the prevention and treatment of bone metastases
Tel: +44 (0) 114 230 5474
Since the mid 1980s Rob’s main research interest has been into cancer induced bone disease especially with relevance to breast cancer. His research in this area is internationally recognised and has included a range of clinical aspects of care, the development of bone targeted agents in oncology, evaluation of bone markers in oncology to aid drug development and provide both prognostic and predictive information in the management of metastatic bone disease, and the assessment of adverse effects of cancer treatments on bone health and evaluation of various treatment strategies. He established a laboratory based translational programme of bone oncology research more than 20 years ago that is now run by Professor Ingunn Holen and Dr Penny Ottewell.
Rob Coleman has authored or co-authored more than 450 publications of original research and many book chapters. He is the founding editor of Journal of Bone Oncology, on the editorial board of several oncology journals and a reviewer for numerous journals. Although now retired from his formal position within the university he remains research active and provides consultancy services to a range of medical education and pharmaceutical companies.